ARCHIVES

Raloxifene Protects Women At High or Low Risk of Disease

This article is from The Cancer Letter archive.

Vol. 29 No. 9 | September 29, 2006

Download PDF Visit The Full Archive

Related Articles

BRAF Inhibitor Shrank Tumors In Phase II Genentech Study

November 26, 2010

NIH Forming Special Emphasis Panel To Review Clinical Oncology Grants

September 18, 1998

DCPC Advisors Request New Study Section In Prevention And Control Of Chronic Disease

July 30, 1993

Science Policy: NI DOD Begins Project For Common Coding Of Cancer Grants

April 2, 1999

In Brief: Mauer to Leave St. Jude For U. Tennessee As Cancer Program Director; Harvard, MIT Share ACS Award

July 29, 1983

White House To Appoint Richard Klausner, Molecular Biologist, As NCI’s 11th Director

July 28, 1995